COMPOSITIONS PHARMACEUTIQUES TRANSDERMIQUES MULTICOUCHES AYANT UN EFFET PROLONGE ET PROCEDE POUR LES PREPARER

LA PRESENTE INVENTION EST RELATIVE A UNE COMPOSITION PHARMACEUTIQUE TRANSDERMIQUE.CETTE COMPOSITION COMPREND UNE OU PLUSIEURS COUCHES CONTENANT LE PRINCIPE ACTIF, UNE COUCHE DE REGULATION ET UNE COUCHE ADHESIVE APPLIQUEES SUR UN SUPPORT.APPLICATION : MEDICAMENTS A EFFET PROLONGE. The invention relat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LASZLO PALLOS, IREN BARTA, LAJOS MAHR, PAL FEKETE, GABOR KOVACS
Format: Patent
Sprache:fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:LA PRESENTE INVENTION EST RELATIVE A UNE COMPOSITION PHARMACEUTIQUE TRANSDERMIQUE.CETTE COMPOSITION COMPREND UNE OU PLUSIEURS COUCHES CONTENANT LE PRINCIPE ACTIF, UNE COUCHE DE REGULATION ET UNE COUCHE ADHESIVE APPLIQUEES SUR UN SUPPORT.APPLICATION : MEDICAMENTS A EFFET PROLONGE. The invention relates to a transdermal laminated pharmaceutical composition (plaster) having prolonged effect, wherein one or more storing layer(s) comprising the active ingredient, an ethylene/vinyl acetate copolymer regulating layer and an adhesive layer are applied onto the carrier. The pharmaceutical composition is prepared by coupling a carrier comprising the active ingredient with a regulating layer consisting of an ethylene/vinyl acetate copolymer foil having a vinal acetate content of 2-40 molar %. The foil is previously irradiated in a thickness of 100-300 mu m with a high-energy irradiation in a dose of 1-15 Mrad-preferably with electrone radiation-and thereafter stretched at 80 DEG -90 DEG C. to a thickness of 2-200 mu m. The system comprising the carrier and the regulating layer is subsequently coupled with an adhesive layer.